highly significantP < 0.001
Moreover, silymarin (group V) pretreatment produced highly significant reduction ( P < 0.001) in serum AST, ALT, ALP, γ-GT and bilirubin level.
Moreover, silymarin (group V) pretreatment produced highly significant reduction ( P < 0.001) in serum AST, ALT, ALP, γ-GT and bilirubin level.